119 related articles for article (PubMed ID: 3764921)
1. Microsomal activation of fluoranthene to mutagenic metabolites.
Babson JR; Russo-Rodriguez SE; Wattley RV; Bergstein PL; Rastetter WH; Liber HL; Andon BM; Thilly WG; Wogan GN
Toxicol Appl Pharmacol; 1986 Sep; 85(3):355-66. PubMed ID: 3764921
[TBL] [Abstract][Full Text] [Related]
2. Mutagenic activity of the 4,5- and 9,10-dihydrodiols of benzo[j]fluoranthene and their syn- and anti-dihydrodiol epoxides in Salmonella typhimurium.
Marshall MV; He ZM; Weyand EH; Rice JE; LaVoie EJ
Environ Mol Mutagen; 1993; 22(1):34-45. PubMed ID: 8339723
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of 7,8-dihydrobenzo(a)pyrene by rat liver microsomal enzymes and mutagenicity of metabolites.
Chiu PL; Yang SK
Cancer Res; 1986 Oct; 46(10):5084-94. PubMed ID: 3756866
[TBL] [Abstract][Full Text] [Related]
4. Mutagenic and cell-transforming activities of triol-epoxides as compared to other chrysene metabolites.
Glatt H; Seidel A; Bochnitschek W; Marquardt H; Marquardt H; Hodgson RM; Grover PL; Oesch F
Cancer Res; 1986 Sep; 46(9):4556-65. PubMed ID: 3524815
[TBL] [Abstract][Full Text] [Related]
5. Metabolic activation of racemic and enantiomeric trans-8, 9-dihydroxy-8,9-dihydrodibenzo[a,l]pyrene (dibenzo[def,p]chrysene) to dibenzo[a,l]pyrene-bis-dihydrodiols by induced rat liver microsomes and a recombinant human P450 1A1 system: the role of the K-region-derived metabolic intermediates in the formation of dibenzo[a,l]pyrene-DNA adducts.
Nesnow S; Davis C; Padgett W; George M; Lambert G; Meyers F; Allison J; Adams L; King LC
Chem Res Toxicol; 1998 Dec; 11(12):1596-607. PubMed ID: 9860506
[TBL] [Abstract][Full Text] [Related]
6. Fluoranthene metabolism: human and rat liver microsomes display different stereoselective formation of the trans-2,3-dihydrodiol.
Day BW; Sahali Y; Hutchins DA; Wildschütte M; Pastorelli R; Nguyen TT; Naylor S; Skipper PL; Wishnok JS; Tannenbaum SR
Chem Res Toxicol; 1992; 5(6):779-86. PubMed ID: 1489928
[TBL] [Abstract][Full Text] [Related]
7. Activation of benzo[a]pyrene and aflatoxin B1 to mutagenic chemical species by microsomal preparations from rat liver and small intestine in relation to microsomal epoxide hydrolase.
Walters JM; Combes RD
Mutagenesis; 1986 Jan; 1(1):45-8. PubMed ID: 3125402
[TBL] [Abstract][Full Text] [Related]
8. Genotoxicity characteristics of reverse diol-epoxides of chrysene.
Glatt H; Wameling C; Elsberg S; Thomas H; Marquardt H; Hewer A; Phillips DH; Oesch F; Seidel A
Carcinogenesis; 1993 Jan; 14(1):11-9. PubMed ID: 8425257
[TBL] [Abstract][Full Text] [Related]
9. Identification of mutagenic dihydrodiols as metabolites of benzo(j)fluoranthene and benzo(k)fluoranthene.
LaVoie EJ; Hecht SS; Amin S; Bedenko V; Hoffmann D
Cancer Res; 1980 Dec; 40(12):4528-32. PubMed ID: 7002294
[TBL] [Abstract][Full Text] [Related]
10. Fungal metabolism and detoxification of fluoranthene.
Pothuluri JV; Heflich RH; Fu PP; Cerniglia CE
Appl Environ Microbiol; 1992 Mar; 58(3):937-41. PubMed ID: 1575497
[TBL] [Abstract][Full Text] [Related]
11. In vitro DNA-binding of microsomally-activated fluoranthene: evidence that the major product is a fluoranthene N2-deoxyguanosine adduct.
Babson JR; Russo-Rodriguez SE; Rastetter WH; Wogan GN
Carcinogenesis; 1986 Jun; 7(6):859-65. PubMed ID: 3708750
[TBL] [Abstract][Full Text] [Related]
12. Metabolic activation to a mutagen of 3-hydroxy-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene, a secondary metabolite of benzo[a]pyrene.
Glatt H; Seidel A; Ribeiro O; Kirkby C; Hirom P; Oesch F
Carcinogenesis; 1987 Nov; 8(11):1621-7. PubMed ID: 3311446
[TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of the major fluoranthene-hemoglobin adducts formed in vivo in the rat.
Hutchins DA; Skipper PL; Naylor S; Tannenbaum SR
Cancer Res; 1988 Sep; 48(17):4756-61. PubMed ID: 3409217
[TBL] [Abstract][Full Text] [Related]
14. Regioselectivity and stereoselectivity in the metabolism of trans-1,2-dihydroxy-1,2-dihydrobenz[a]anthracene by rat liver microsomes.
Vyas KP; van Bladeren PJ; Thakker DR; Yagi H; Sayer JM; Levin W; Jerina DM
Mol Pharmacol; 1983 Jul; 24(1):115-23. PubMed ID: 6865920
[TBL] [Abstract][Full Text] [Related]
15. Stereoselective metabolism of dibenz[a,h]acridine to bay-region diol epoxides by rat liver microsomes.
Kumar S; Singh SK; Kole PL; Elmarakby S; Sikka HC
Carcinogenesis; 1995 Mar; 16(3):525-30. PubMed ID: 7697809
[TBL] [Abstract][Full Text] [Related]
16. Species-specific enhancement by 7,8-benzoflavone of hepatic microsomal metabolism of benzo[e]pyrene 9,10-dihydrodiol to bay-region diol epoxides.
Thakker DR; Levin W; Buening M; Yagi H; Lehr RE; Wood AW; Conney AH; Jerina DM
Cancer Res; 1981 Apr; 41(4):1389-96. PubMed ID: 7194138
[TBL] [Abstract][Full Text] [Related]
17. Microsomal metabolism of the food mutagen 2-amino-3,4,8-trimethyl-3H-imidazo[4,5-f]-quinoxaline to mutagenic metabolites.
Frandsen H; Nielsen PA; Grivas S; Larsen JC
Mutagenesis; 1994 Jan; 9(1):59-65. PubMed ID: 8208131
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of 3-hydroxybenzo(a)pyrene on the mutagenicity and tumorigenicity of (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene.
Huang MT; Wood AW; Chang RL; Yagi H; Sayer JM; Jerina DM; Conney AH
Cancer Res; 1986 Feb; 46(2):558-66. PubMed ID: 3079665
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of the bay-region diol-epoxide of chrysene to a triol-epoxide and the enzyme-catalysed conjugation of these epoxides with glutathione.
Hodgson RM; Seidel A; Bochnitschek W; Glatt HR; Oesch F; Grover PL
Carcinogenesis; 1986 Dec; 7(12):2095-8. PubMed ID: 3779903
[TBL] [Abstract][Full Text] [Related]
20. Identification of metabolites of benzo[j]fluoranthene formed in vitro in rat liver homogenate.
Rice JE; Geddie NG; Lavoie EJ
Chem Biol Interact; 1987; 63(3):227-37. PubMed ID: 3677219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
